Ophthalmology Ltd. | Clinical Research

Clinical Research

In addition to providing top-quality care for your eyes, the team at Ophthalmology LTD is dedicated to advancing research and improving outcomes. As part of this mission, we participate in clinical research programs.

Our experienced research team, supported by state-of-the-art diagnostic imaging technologies, remains dedicated to exploring new approaches. This ongoing pursuit ensures improved, forward-thinking care for patients affected by a variety of eye disorders, offering hope through participation in promising clinical trials.

For information on any of our research trials, please reach out to our clinical trial team at our main office.

Current Clinical Trials at Ophthalmology LTD

Actively Enrolling

PEAK – Macular Edema Secondary to Inflammation

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI)

PINNACLE – Macular Edema Secondary to Inflammation

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI)

RHÔNE – Ocular Hypertension (OHT), Open Angle Glaucoma (OAG), Cataracts

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)

Active Trials (Enrollment Closed)

DAYBREAK – Neovascular (Wet) Age-Related Macular Degeneration

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

K8GA – Geographic Atrophy Secondary to Age Related Macular Degeneration

Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy (K8 for GA)